Vetoryl 10 mg – Trilostane Capsules for Dogs

Vetoryl 10 mg contains Trilostane, a competitive inhibitor of the enzyme 3-β-hydroxysteroid dehydrogenase. It is used in dogs for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism (Cushing’s syndrome).
By reducing cortisol production, Vetoryl helps restore hormonal balance, alleviating symptoms such as excessive thirst and urination, hair loss, and panting.

Key Benefits

• Controls Cushing’s syndrome by regulating cortisol secretion

• Improves energy, appetite, and skin/coat condition

• Supports healthy adrenal gland function

• Well-tolerated and clinically proven in long-term management

• Easy-to-administer hard gelatin capsules

Active Ingredient (per capsule)

• Trilostane – 10 mg

Indications

• Treatment of pituitary-dependent hyperadrenocorticism (PDH)

• Treatment of adrenal-dependent hyperadrenocorticism (ADH)

Dosage & Administration

• Administer once daily with food or as directed by a licensed veterinarian.

• Dosage is based on body weight and individual response; regular monitoring of cortisol levels is required.

• Capsules must be given whole — do not divide or open.

Precautions

• For use in dogs only.

• Not for use in dogs with liver, kidney, or heart disease, or in pregnant animals.

• Monitor for adverse reactions such as vomiting, lethargy, or loss of appetite.

• Veterinary supervision and periodic testing are essential.

Packaging

30 hard capsules (10 mg each)

Storage

Store below 25 °C, in a dry place, away from children and animals.

Restore balance and vitality to dogs with Vetoryl 10 mg — the trusted Trilostane therapy for safe, effective, and clinically proven control of Cushing’s syndrome.

Important Notice:

This is a veterinary prescription product. To ensure the health and safety of your pet, purchase approval is required.
After placing your order, please share your dog’s medical prescription via WhatsApp with the clinic team for verification.
Orders will only be processed once a valid prescription has been reviewed and approved.